ArticleCommunications biology2026

Dual targeting of glutamine metabolism and lysosomal function in eliminating drug-tolerant KRAS-mutant cancer cells.

Hiroki Furukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.